跳至主要内容
临床试验/IRCT2015052022340N1
IRCT2015052022340N1已完成2 期

Clinical trial on comparison of levetiracetam monotherapy and sodium valproate monotherapy on quality of life and seizure control in patients with brain tumor-related epilepsy

Vice chancellor for research of Isfahan University of medical sciences0 个研究点目标入组 23 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 no limit(—)
性别
All

入选标准

  • Patients with brain tumors and epilepsy characterized by simple or complex partial seizures, with or without secondary generalization; Patients who had at least one seizure prior to having been referred to our center, who had never undergone prior anti-epileptic drug (AED) therapy; Patients who had received previous AED (with a verification that the previous AEDs had been in the therapeutic range but not controlled; Patients with severe side effects with previous AED therapy.
  • Exclusion criteria: Patients with epilepsy prior to tumor onset; Patient with known sever liver disease for Sodium-Valproate group.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Isfahan University of medical sciences

相似试验